Lupin Limited has informed the Exchange regarding a press release dated February 16, 2024, titled "Lupin Receives Approval from U.S. FDA for MinzoyaTM (Levonorgestrel and EthinylEstradiol Tablets, USP and Ferrous Bisglycinate Tablets).".
Lupin Limited has informed the Exchange regarding a press release dated February 16, 2024, titled "Lupin Receives Approval from U.S. FDA for MinzoyaTM (Levonorgestrel and EthinylEstradiol Tablets, USP and Ferrous Bisglycinate Tablets).".